Saudi Arabia National Guard Healthcare Management Leadership Programme

Posted: 11th January 2019

In 2018 we delivered the ‘Cambridge Clinical Leadership Programme’ to King Saud Bin Abdulaziz University for Health Sciences in Riyadh.

The Saudi Arabia Ministry Of National Guard-Health Affairs (MNG-HA) is a publicly-funded multi-specialty academic accountable health system. It integrates clinical care with research and education. MNG-HA was founded in 1982 with a vision of providing outstanding patient care to its eligible local population . The system has seen significant development and expansion across Saudi Arabia in the last few years and it now has five medical cities, specialist hospitals and 71 Primary Healthcare Centers. The Health system has a total of 25,000 employees, 3444 hospital beds, 106,040 inpatient admissions and 2,358,470 outpatient visits in 2017. A key organisational challenge is utilising the specialist hospitals and health care centres to meet the increased demand for health, while maintaining the focus on delivering efficient, effective, safe and integrated care to its patients. The MNG-HA ambition is to be the national centre of excellence for clinical executive training and development.

Picture of Moller Saudi Arabia Ministry Of National Guard-Health Affairs

Design

The Møller Institute executive education team partnered with Ministry Of National Guard-Health Affairs to design two programmes –  the National Guard Clinical Leadership Programme and National Guard Healthcare Management Leadership Programme which were both open to all Saudi Arabia Healthcare professionals. We designed the highly-customised healthcare leadership programmes to include challenging talks by exceptional Cambridge academics and healthcare practitioners with a wealth of knowledge and expertise. The collaboration during the design phase allowed for the sharing of industry insights and bilateral learning which enabled MNG-HA healthcare leaders to deliver the organisation vision, implement changes and address the critical challenges facing health care.

The programmes targeted C-Suite Clinical Executives focused on Executive Leadership Development, Organisational Development and Culture, Healthcare Transformation and Innovation.

Delivery

We delivered the programmes in Riyadh, Saudi Arabia, to 80 hospital CEOs, middle managers, medical directors and civil servants who came from each of three service providers that comprise of Saudi’s healthcare system – the Ministry of Health (MoH) hospitals, government hospitals and private hospitals.

  • develop the participants’ strategic planning and leadership skills
  • give participants a good understanding of the UK healthcare system, including primary, secondary care and social care
  • facilitate comparisons between the UK and the Saudi Arabia healthcare systems with a view to adapt good practice in the UK for Saudi Arabia healthcare reform
  • help participants understand the UK clinical quality framework and organisation development with a view to develop the current structure/practice in Saudi Arabia
  • give participants the opportunity to exchange views with their UK counterparts on a variety of topics such as innovation in health care.

Practical impact

On completion of the programmes participants were able to compare and identify the differences between British and Saudi Arabia healthcare systems. The reflection and discussions on the programmes, including a debate how a GP/Medical Practice model would benefit big medical cities in Saudi Arabia, has enabled the leaders to better analyse the major challenges and issues Saudi Arabia is facing during the healthcare reform and development.  The programmes gave them the tools to design, introduce, and sustain policies and procedures that benefit the Saudi Arabia healthcare system.

The healthcare leaders were able to engage and interact with experts in the UK healthcare sector to learn from their best practice on hospital organisation development, talent management, public private partnerships, delivering clinical excellence as well as improve efficiency. Participants are now able to more effectively support the integration of academic research and clinical trials to better facilitate medical innovation.